USA - NASDAQ:ARGX - US04016X1019 - ADR
Overall ARGX gets a fundamental rating of 6 out of 10. We evaluated ARGX against 534 industry peers in the Biotechnology industry. While ARGX has a great health rating, its profitability is only average at the moment. ARGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make ARGX suitable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 6.01% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 29.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.06 | ||
| Fwd PE | 31.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 165.42 | ||
| EV/EBITDA | 91.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ARGX (10/27/2025, 1:38:00 PM)
829.46
+12.14 (+1.49%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.06 | ||
| Fwd PE | 31.41 | ||
| P/S | 16.74 | ||
| P/FCF | 165.42 | ||
| P/OCF | 126.48 | ||
| P/B | 8.38 | ||
| P/tB | 8.69 | ||
| EV/EBITDA | 91.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROCE | 7.61% | ||
| ROIC | 6.01% | ||
| ROICexc | 16.72% | ||
| ROICexgc | 18.56% | ||
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% | ||
| FCFM | 10.12% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.07 | ||
| Cap/Depr | 428.74% | ||
| Cap/Sales | 3.12% | ||
| Interest Coverage | 519.07 | ||
| Cash Conversion | 82.6% | ||
| Profit Quality | 24.11% | ||
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 | ||
| Altman-Z | 29.39 |
ChartMill assigns a fundamental rating of 6 / 10 to ARGX.
ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE - ADR (ARGX). This can be considered as Fairly Valued.
ARGENX SE - ADR (ARGX) has a profitability rating of 5 / 10.
The Earnings per Share (EPS) of ARGENX SE - ADR (ARGX) is expected to grow by 805.38% in the next year.